Search

everythinglearnresearchcommunity

for

Search:↓

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Electrochemotherapy successfully treated skin tumors in cats without recurrence.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Baricitinib helps with early hair regrowth in people with alopecia areata.

Baicapil was effective in reducing hair loss and increasing hair growth in women with telogen effluvium.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Abatacept may help some people with alopecia areata regrow hair.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Radiation therapy successfully treated an elderly man's skin cancer and pre-cancerous scalp lesions.

Radiation therapy successfully treated an elderly man's skin cancer and pre-cancerous scalp lesions.

Caffeine reduces radiation skin damage but doesn't affect tumor treatment.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

The nano-carrier makes etoposide safer and more effective against lung cancer.